| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.28B | 1.41B | 1.69B | 1.67B | 1.39B | 1.22B |
| Gross Profit | 487.10M | 454.70M | 471.90M | 570.10M | 512.80M | 465.50M |
| EBITDA | 141.10M | -329.50M | 206.00M | 440.20M | 324.40M | 382.40M |
| Net Income | -65.90M | -430.30M | -5.40M | 211.60M | 118.10M | 181.40M |
Balance Sheet | ||||||
| Total Assets | 1.83B | 2.02B | 2.62B | 2.74B | 2.47B | 2.33B |
| Cash, Cash Equivalents and Short-Term Investments | 83.40M | 68.00M | 95.90M | 76.70M | 275.40M | 257.70M |
| Total Debt | 1.29B | 1.45B | 1.53B | 1.53B | 1.32B | 1.34B |
| Total Liabilities | 1.70B | 1.83B | 1.99B | 2.04B | 1.80B | 1.69B |
| Stockholders Equity | 138.10M | 195.20M | 631.40M | 698.30M | 673.80M | 642.10M |
Cash Flow | ||||||
| Free Cash Flow | 239.60M | 51.00M | 95.30M | 170.90M | 189.50M | 246.50M |
| Operating Cash Flow | 298.60M | 128.60M | 205.10M | 313.40M | 293.30M | 352.40M |
| Investing Cash Flow | -70.40M | -79.50M | -77.30M | -551.90M | -138.60M | -110.60M |
| Financing Cash Flow | -266.40M | -70.20M | -99.90M | 48.10M | -133.10M | -50.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | $1.16B | 25.87 | 3.67% | 3.33% | 5.35% | -1.43% | |
64 Neutral | $2.06B | -2,497.74 | -0.09% | 0.74% | -2.53% | -100.23% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | $2.85B | -3.52 | -34.45% | 2.79% | -13.67% | -608.89% | |
59 Neutral | $2.32B | -35.87 | -38.91% | ― | -13.39% | 88.25% | |
58 Neutral | $2.62B | -297.82 | -0.64% | 1.37% | 0.08% | -107.33% | |
54 Neutral | $1.98B | -1,370.24 | -0.09% | 2.19% | -4.49% | -100.80% |
On January 1, 2026, Ingevity amended its asset purchase agreement related to the sale of certain businesses by excluding non-lignin dispersant products sold for agricultural chemical applications from the asset package. On the same date, the buyer acquired substantially all assets and certain rights and liabilities tied to Ingevity’s industrial specialties product line—excluding specified businesses—and its North Charleston, South Carolina crude tall oil (CTO) refinery and related operations. On January 5, 2026, Ingevity announced it had completed the all-cash sale of its North Charleston CTO refinery assets and the majority of its Performance Chemicals Industrial Specialties product line to Mainstream Pine Products, LLC for $110 million at closing plus up to $19 million in contingent consideration, subject to post-closing adjustments. Management framed the divestiture as a pivotal move to simplify and streamline the portfolio, reduce earnings volatility, and strengthen margins and cash flow, while sharpening the company’s focus on higher-margin specialty applications in activated carbon and pavement technologies and retaining its Pavement Technologies business and other lignin-based dispersant products.
The most recent analyst rating on (NGVT) stock is a Hold with a $60.00 price target. To see the full list of analyst forecasts on Ingevity stock, see the NGVT Stock Forecast page.
On December 8, 2025, Ingevity Corporation announced the completion of its portfolio review and the exploration of strategic alternatives for its Advanced Polymer Technologies segment and Performance Chemicals Road Markings business. The company aims to enhance its portfolio by potentially divesting these segments to focus on core businesses with superior margins and cash flow. Ingevity has also completed over $30 million in stock repurchases in the fourth quarter of 2025, reflecting its commitment to returning capital to shareholders. The strategic review is part of Ingevity’s efforts to build a more agile enterprise and maximize shareholder value, although it is uncertain if it will result in any transactions.
The most recent analyst rating on (NGVT) stock is a Hold with a $53.00 price target. To see the full list of analyst forecasts on Ingevity stock, see the NGVT Stock Forecast page.
On December 8, 2025, Ingevity Corporation announced significant leadership changes as part of its strategic portfolio review. Mary Dean Hall will transition from her role as CFO on May 1, 2026, with Phillip J. Platt appointed as her successor. Rich White, President of Performance Chemicals, will move to a special projects role before departing on May 1, 2026. Additionally, Reid Clontz has been appointed as Senior Vice President of Operations. These transitions are aimed at supporting Ingevity’s long-term growth and strategic priorities.
The most recent analyst rating on (NGVT) stock is a Hold with a $53.00 price target. To see the full list of analyst forecasts on Ingevity stock, see the NGVT Stock Forecast page.
On September 3, 2025, Ingevity Corporation announced an Asset Purchase Agreement with Mainstream Pine Products, LLC to sell its industrial specialties product line and North Charleston crude tall oil refinery, marking a strategic shift for the company. This divestiture, expected to close by early 2026, will significantly impact Ingevity’s operations and financial results, as these assets are now classified as discontinued operations.
The most recent analyst rating on (NGVT) stock is a Hold with a $55.00 price target. To see the full list of analyst forecasts on Ingevity stock, see the NGVT Stock Forecast page.
On October 23, 2025, Ingevity Corporation announced the appointment of Ruth Castillo as Senior Vice President and President of Performance Materials, effective November 10, 2025. Castillo, with over 25 years of experience in the chemicals and materials industries, will lead Ingevity’s activated carbon segment, focusing on innovation and strategic growth. Her leadership is expected to reinforce the segment’s market position in evaporative emissions control and expand into emerging applications, aligning with Ingevity’s goals for operational excellence and market-driven priorities.
The most recent analyst rating on (NGVT) stock is a Buy with a $69.00 price target. To see the full list of analyst forecasts on Ingevity stock, see the NGVT Stock Forecast page.